At the Lab
Each episode features a CSHL researcher or educator focused on the biggest global issues and scientific mysteries of the past, present, and future—from deadly diseases to climate change.
Tune in to hear our latest bioscience breakthrough broken down in 3 minutes or less.
Subscribe: Apple | Podbean | Spotify | YouTube | Amazon Alexa device
At the Lab Season 1 Research Rewind: Cancer
As the first season of our new podcast winds down, we’re revisiting all of our episodes with a focus on CSHL’s cutting-edge cancer research.
At the Lab Episode 26: The golden grail of genomics
For our Season 1 finale, we invite you to step inside EN-TEx, a catalog of more than one million genomic variants.
At the Lab Episode 25: How maize became corn
Cold Spring Harbor Laboratory solves a plant biology mystery some 4,000 years in the making. The implications may go far beyond vegetables.
At the Lab Episode 24: Putting the brakes on brain cancer
CSHL Professor Alea Mills compares the deadly brain cancer glioblastoma to a car with its brakes cut. Her lab works to reattach them.
At the Lab Episode 23: Cured with CRISPR
Victoria Gray, the first person ever cured of sickle cell, appeared on a DNA Learning Center panel featuring a clinical scientist from CSHL.
At the Lab Episode 22: Outmuscling cancer
After 10 years, CSHL has made a breakthrough in the study of RMS, a rare pediatric cancer. How we got here is a story of innovation and perseverance.
At the Lab Episode 21: Nature versus nurture
What makes you, you? CSHL Assistant Professor Gabrielle Pouchelon looks for answers in the brain’s earliest neural connections.
At the Lab Episode 20: Cleanup on IL-6
CSHL Professor Bo Li set out to study a tiny group of neurons involved in cancer cachexia. What he found astounded even him.
At the Lab Episode 19: Brain sex
How are sex differences defined in the brain? CSHL Associate Professor Jessica Tollkuhn delivers a thought-provoking primer on a fascinating topic.
At the Lab Episode 18: The stress of cancer
A sobering conversation on a breakthrough discovery with potentially significant implications for cancer patients everywhere.